Conference to Focus on Optimising Drug Supply and Ensuring Security
ISPE
ISPE (the International Society for Pharmaceutical Engineering) will hold the World Class Supply End-to-End conference, highlighting key challenges and opportunities in the pharmaceutical supply chain, on 13–14 June 2013, in Prague, the Czech Republic. Delegates will gain insights into anti-counterfeiting issues, packaging fraud, pharmacovigilance and effective recall. Legalities around falsified medicines and new obligations for manufacturers and distributors of medicinal products will be covered by an MHRA, Expert GMP/GDP Inspector.
Preliminary results of the global survey on Drug Shortages that ISPE is currently conducting will be introduced during the event. The survey goal is to gather data on the technical, scientific, manufacturing, quality and compliance issues that have resulted in this complex problem.
Jim McKiernan, CEO, McKiernan Associates, conference chair, said: “The industry has made tremendous strides forward in the past decade to improve its supply chain efficiency. However, compared with other sectors, pharma still has a long way to go to achieve truly world-class performance. This conference will allow attendees to hear examples of best practice and gain insights on moving their business forward.”
This two-day conference will provide an opportunity for supply chain and production plant managers, clinical supply professionals, CROs, CMOs, anti-counterfeiting officers and technology transfer specialists to be updated on the latest technological and regulatory developments in pharmaceutical supply chain operations. More than 30 industry and regulatory speakers from organisations such as MHRA, NHS Scotland, Napp, Boehringer Ingelheim and Cemafroid will share their experiences.
ISPE European Operations, +32 2 743 15 53, sabine.dupont@associationhq.com, www.ispe.org/2013-supply-chain-eu-conference.